Joel Wayment discusses the implications of the growing cell and gene therapy market on pharma supply chains. The rise in cell ...
Joydeep Ganguly evaluates 4IR tools, data strategy, and why end-to-end thinking will define pharma supply chain ...
Pharmaceutical cold chain logistics is entering a phase where data quality and decision speed matter as much as physical ...
discusses today's key risks in the pharma supply chain, and how to prevent disruptions.
Gross-to-net concessions exceeding half of U.S. brand revenue make minor contracting and payment inefficiencies translate into hundreds of millions in leakage or compliance risk. Legacy revenue ...
Following his keynote address at LogiPharma Europe 2026, Nico Vandaele, professor of Operations Research & Operations ...
Regulatory expectations increasingly demand evidence of in-transit control, emphasizing data integrity, auditability, and ...
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast in which we bring you the latest insights shaping patient access, ...
Eli Lilly has entered a definitive agreement to acquire Kelonia Therapeutics for up to $7 billion. The centerpiece of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results